cDNA encoding the C-terminal domain (nt2283 to 3714) of type 111 collagen was amplified by PCR in five overlapping products and examined for mutations in 13 patients with Ehlers-Danlos syndrome type 1V (EDS 1V) with uncharacterised lesions and in five control patients with known single base mutation
The efficiency of laser for the treatment of Ehlers–Danlos syndrome
✍ Scribed by Daniel F. Mueller; Alexander Zimmermann; Claudia Borelli
- Publisher
- John Wiley and Sons
- Year
- 2005
- Tongue
- English
- Weight
- 127 KB
- Volume
- 36
- Category
- Article
- ISSN
- 0196-8092
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Background and Objectives
A 61‐year‐old woman presented herself with extensive elastosis of the facial skin caused by Ehlers–Danlos syndrome (EDS).
Study Design/Materials and Methods
Two laser skin resurfacings reduced the wrinkles significantly better than the two preceding conventional facelifts. For the first time, we have been able to compare two treatments with different laser systems on the same patient. The first treatment was performed with a high energy pulsed CO~2~ laser, which has been in use for 8 years. The second treatment was performed by us using the latest technology CO~2~/erbium:YAG combination laser.
Results/Conclusion
Resulting in a similar degree of wrinkle reduction, the treatment with the combination laser markedly reduced the duration of the healing process and erythema phase. Lasers Surg. Med. 36:76–78, 2005. © 2005 Wiley‐Liss, Inc.
📜 SIMILAR VOLUMES
## Abstract Skin fibroblasts derived from Ehlers‐Danlos syndrome (EDS) patients lack an organized extracellular matrix (ECM) of fibronectin (FN) and often show an accumulation of cytoplasmic FN. The treatment of EDS cells of different types (I to VIII) with 10‐^7^ M dexamethasone (dex), as well as